Keyphrases
Public TCR
100%
Public T Cell Receptors
100%
Outcome Prediction
100%
Cancer Patients
100%
Specific Intent
50%
Immunotherapy Trials
25%
Long-term Control
25%
Immunophenotypic Profile
25%
Predictive Value
25%
T-cell Receptor Sequencing
25%
Cancer-specific
25%
Prognostic Value
25%
Lung Cancer
25%
Bead-based
25%
T Cell Receptor
25%
Overall Survival
25%
Diverse Populations
25%
Trial Network
25%
Cancer Immunotherapy
25%
Clinical Outcomes
25%
Melanoma Patients
25%
Checkpoint Inhibitors
25%
Progression-free Survival
25%
Peripheral Blood
25%
Cell Sorting
25%
Renal Cell Carcinoma
25%
RNA-seq Analysis
25%
Predictive Power
25%
Flow-based
25%
Immunology and Microbiology
T Cell Receptor
100%
Cell Selection
14%
Awareness
14%
Human Immunodeficiency Virus
14%
Progression Free Survival
14%
RNA Sequence
14%
Carcinoma Cell
14%
Melanoma Cell
14%
Overall Survival
14%
Cancer Immunotherapy
14%
Immunotherapy
14%
Biochemistry, Genetics and Molecular Biology
T Cell Receptor
100%
Awareness
14%
RNA Sequence
14%
Human Immunodeficiency Virus
14%
Overall Survival
14%
Progression Free Survival
14%
Cell Selection
14%
Cancer Immunotherapy
14%